Pharmacutical Orthokeratology Market : Consumption, Revenue | Page 2

REPORT DESCRIPTION
Orthokeratology Market – Overview
Orthokeratology (Ortho-k) is a process that uses specially designed contact lenses to temporarily reshape
outline of the cornea to reduce myopia (nearsightedness). It is a non-surgical procedure, which offers
advantage of reduced risk in comparison to refractive surgery. Ortho-k lenses are also termed as corneal
reshaping contact lenses or overnight contact lenses to correct or control myopia.
These lenses are prescribed to correct refractive errors primarily nearsightedness, astigmatism, and
hyperopia. In some cases, ortho-k is also used to correct presbyopia and to slow the progression of
childhood myopia. According to a study published by American Academy of Optometry 2015, use of
orthokeratology lenses led to a consistent reduction in myopia progression of around 45% for a period of
two-year and 30% over five years, in terms of axial length.
The global orthokeratology market size was valued at US$ 37.6 million in 2017, and is expected to witness
a CAGR of 7.0% over the forecast period (2018 – 2026).
© Coherent market Insights. All Rights Reserved